Take for instance, targeting histone methyltransferase EZH2 (zeste homolog 2) significantly alleviates intestinal inflammation, EZH2 is correlated with colorectal cancer stage and prognosis, linked to CRC tumorigenesis11–13. Here, PRDM9 is linked to colorectal cancer.